Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

The inflammasome: a remote control for metabolic syndrome.

Lamkanfi M, Kanneganti TD.

Cell Res. 2012 Jul;22(7):1095-8. doi: 10.1038/cr.2012.55. Epub 2012 Apr 10. No abstract available.

2.

The innate immune response during liver inflammation and metabolic disease.

Bieghs V, Trautwein C.

Trends Immunol. 2013 Sep;34(9):446-52. doi: 10.1016/j.it.2013.04.005. Epub 2013 May 11. Review.

PMID:
23668977
3.

Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis.

Szabo G, Iracheta-Vellve A.

Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S18-23. doi: 10.1016/j.clinre.2015.06.012. Epub 2015 Jul 26. Review.

PMID:
26216030
4.

[Metabolic syndrome and liver: the role of leptin].

Ikejima K, Sato N.

Nihon Shokakibyo Gakkai Zasshi. 2005 Nov;102(11):1392-7. Japanese. No abstract available.

PMID:
16318378
5.

NASH--hepatic metabolism and not simply the metabolic syndrome.

Green RM.

Hepatology. 2003 Jul;38(1):14-7. Review. No abstract available.

PMID:
12829980
6.

The cardiometabolic syndrome and liver disease.

Sowers JR.

J Cardiometab Syndr. 2008 Winter;3(1):5-6. No abstract available.

7.

Iron, metabolic syndrome, nonalcoholic fatty liver disease and carotid atherosclerosis.

Mascitelli L, Pezzetta F, Goldstein MR.

Atherosclerosis. 2009 Jul;205(1):39-40. doi: 10.1016/j.atherosclerosis.2008.12.021. Epub 2008 Dec 24. No abstract available.

PMID:
19155012
8.

[Glucotoxicity, lipotoxicity and the nonalcoholic fatty liver disease].

Zeng MD.

Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):81-2. Chinese. No abstract available.

PMID:
15727688
9.

Non-alcoholic fatty liver disease and the metabolic syndrome: an update.

Rector RS, Thyfault JP, Wei Y, Ibdah JA.

World J Gastroenterol. 2008 Jan 14;14(2):185-92. Review.

10.

Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease.

Baranova A, Randhawa M, Jarrar M, Younossi ZM.

Expert Rev Mol Diagn. 2007 Mar;7(2):195-205. Review.

PMID:
17331066
11.

[Nonalcoholic fatty liver disease and metabolic syndrome: equality of pathogenetic mechanisms and therapeutic approaches].

Tkachenko EI, Uspenskiń≠ IuP, Belousova LN, Petrenko VV.

Eksp Klin Gastroenterol. 2008;(2):92-6. Russian. No abstract available.

PMID:
19145872
12.

Fatty liver in HIV infection: metabolic syndrome, medicines, mitochondria, and more?

Gholam PM, McComsey GA.

AIDS Read. 2007 Oct;17(10):516-7. No abstract available.

PMID:
17990374
13.

Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.

Dumas ME, Kinross J, Nicholson JK.

Gastroenterology. 2014 Jan;146(1):46-62. doi: 10.1053/j.gastro.2013.11.001. Epub 2013 Nov 7.

PMID:
24211299
14.

Clinical observation paper: fatty liver and metabolic syndrome: is it a burden for the future generations?

Nobili V, Agostoni C.

Metabolism. 2010 Jun;59(6):831-3. doi: 10.1016/j.metabol.2009.09.031. Epub 2009 Dec 16. No abstract available.

PMID:
20005539
15.

Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?

Caldwell SH, Ikura Y, Iezzoni JC, Liu Z.

J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S11-9. Review. Erratum in: J Gastroenterol Hepatol. 2008 Mar;23(3):501-2.

PMID:
17567458
16.

Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome.

Fujimoto M, Tsuneyama K, Fujimoto T, Selmi C, Gershwin ME, Shimada Y.

Dig Liver Dis. 2012 Sep;44(9):767-74. doi: 10.1016/j.dld.2012.02.002. Epub 2012 Mar 22.

PMID:
22444524
17.

Obesity, metabolic syndrome, and microbiota: multiple interactions.

Tilg H.

J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S16-8. doi: 10.1097/MCG.0b013e3181dd8b64.

PMID:
20535027
18.

Metabolic syndrome and non-alcoholic fatty liver disease.

Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA.

Ann Hepatol. 2009;8 Suppl 1:S18-24. Review.

PMID:
19381120
19.

Nonalcoholic fatty liver and insulin resistance among petrochemical workers.

Cotrim HP, Carvalho F, Siqueira AC, Lordelo M, Rocha R, De Freitas LA.

JAMA. 2005 Oct 5;294(13):1618-20. No abstract available.

PMID:
16204660
20.

The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease.

Monteiro J, Leslie M, Moghadasian MH, Arendt BM, Allard JP, Ma DW.

Food Funct. 2014 Mar;5(3):426-35. doi: 10.1039/c3fo60551e. Review.

PMID:
24496399

Supplemental Content

Support Center